Effectiveness and safety of rivaroxaban vs warfarin in people with non-valvular atrial fibrillation and diabetes: an administrative claims database analysis.

Craig I ColemanT J BunzD ErikssonA-K MeineckeN A Sood

Published in: Diabetic medicine : a journal of the British Diabetic Association (2018)

Rivaroxaban has effectiveness and safety at least as good as those of warfarin in people with diabetes and non-valvular atrial fibrillation treated in routine clinical practice.

Keyphrases

atrial fibrillation
oral anticoagulants
clinical practice
type diabetes
direct oral anticoagulants
catheter ablation
left atrial
cardiovascular disease
left atrial appendage
glycemic control
heart failure
percutaneous coronary intervention
health insurance
venous thromboembolism
adverse drug